Fab Biopharma leads the way in pioneering drug discovery to enhance women’s health. Focused on autoimmune diseases prevalent in women, such as Sjögren’s disease, lupus, and osteoarthritis, we are dedicated to filling critical treatment gaps. Our team, composed of industry veterans specializing in IP, drug development, and clinical research, is advancing a groundbreaking class of bispecific soluble receptors targeting T and B cell-activating cytokines and ligands. Fab Biopharma is committed to advancing safe and effective autoimmune biologics tailored to meet the specific needs of women. Recognizing the differences in female biology, we prioritize innovation in drug science with research and development centered on a female-focused perspective.
Visit Company Website
